207 related articles for article (PubMed ID: 16391839)
1. Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.
Pacher P; Liaudet L; Mabley JG; Cziráki A; Haskó G; Szabó C
Int J Mol Med; 2006 Feb; 17(2):369-75. PubMed ID: 16391839
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure.
Pacher P; Liaudet L; Mabley Jg; Komjáti K; Szabó C
J Am Coll Cardiol; 2002 Sep; 40(5):1006-16. PubMed ID: 12225730
[TBL] [Abstract][Full Text] [Related]
3. Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction.
Radovits T; Seres L; Gero D; Berger I; Szabó C; Karck M; Szabó G
Exp Gerontol; 2007 Jul; 42(7):676-85. PubMed ID: 17383839
[TBL] [Abstract][Full Text] [Related]
4. A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging.
Pacher P; Vaslin A; Benko R; Mabley JG; Liaudet L; Haskó G; Marton A; Bátkai S; Kollai M; Szabó C
J Pharmacol Exp Ther; 2004 Nov; 311(2):485-91. PubMed ID: 15213249
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure.
Xiao CY; Chen M; Zsengellér Z; Li H; Kiss L; Kollai M; Szabó C
J Pharmacol Exp Ther; 2005 Mar; 312(3):891-8. PubMed ID: 15523000
[TBL] [Abstract][Full Text] [Related]
7. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure.
Pacher P; Liaudet L; Bai P; Virag L; Mabley JG; Haskó G; Szabó C
J Pharmacol Exp Ther; 2002 Mar; 300(3):862-7. PubMed ID: 11861791
[TBL] [Abstract][Full Text] [Related]
8. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.
Szabó G; Soós P; Mandera S; Heger U; Flechtenmacher C; Bährle S; Seres L; Cziráki A; Gries A; Zsengellér Z; Vahl CF; Hagl S; Szabó C
Shock; 2004 May; 21(5):426-32. PubMed ID: 15087818
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor.
Xiao CY; Chen M; Zsengellér Z; Szabó C
J Pharmacol Exp Ther; 2004 Aug; 310(2):498-504. PubMed ID: 15054118
[TBL] [Abstract][Full Text] [Related]
11. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
[TBL] [Abstract][Full Text] [Related]
13. Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase.
Korkmaz-Icöz S; Radovits T; Loganathan S; Li S; Ruppert M; Benke K; Brlecic P; Szabó C; Karck M; Szabó G
Eur J Cardiothorac Surg; 2017 May; 51(5):829-835. PubMed ID: 28204209
[TBL] [Abstract][Full Text] [Related]
14. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents.
Pacher P; Cziráki A; Mabley JG; Liaudet L; Papp L; Szabó C
Biochem Pharmacol; 2002 Dec; 64(12):1785-91. PubMed ID: 12445868
[TBL] [Abstract][Full Text] [Related]
15. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
Pacher P; Szabó C
Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
[TBL] [Abstract][Full Text] [Related]
16. Mesenteric injury after cardiopulmonary bypass: role of poly(adenosine 5'-diphosphate-ribose) polymerase.
Szabó G; Soós P; Mandera S; Heger U; Flechtenmacher C; Seres L; Zsengellér Z; Sack FU; Szabó C; Hagl S
Crit Care Med; 2004 Dec; 32(12):2392-7. PubMed ID: 15599141
[TBL] [Abstract][Full Text] [Related]
17. Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival.
Farivar AS; McCourtie AS; MacKinnon-Patterson BC; Woolley SM; Barnes AD; Chen M; Jagtap P; Szabó C; Salerno CT; Mulligan MS
Ann Thorac Surg; 2005 Sep; 80(3):950-6. PubMed ID: 16122462
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.
Khan TA; Ruel M; Bianchi C; Voisine P; Komjáti K; Szabo C; Sellke FW
J Am Coll Surg; 2003 Aug; 197(2):270-7. PubMed ID: 12892811
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of poly(ADP-ribose) polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection.
Szabó G; Bährle S; Sivanandam V; Stumpf N; Gerö D; Berger I; Beller C; Hagl S; Szabó C; Dengler TJ
J Heart Lung Transplant; 2006 Jul; 25(7):794-804. PubMed ID: 16818122
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
